Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The
objective was to develop recommendations for treating JIA to target. A Steering Committee
formulated a set of recommendations based on evidence derived from a systematic literature
review. These were subsequently discussed, amended and voted on by an international
Task Force of 30 paediatric rheumatologists in a consensus-based, Delphi-like procedure …